41776-65-2 Usage
Uses
Used in Pharmaceutical Industry:
(8E,14E,24E)-8-[([(2E)-3,7-dimethylocta-2,6-dien-1-yl]oxyamino)methylidene]-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is used as a potential pharmaceutical agent for its possible biological activities due to its complex and elaborate chemical structure.
Used in Chemical Research:
(8E,14E,24E)-8-[([(2E)-3,7-dimethylocta-2,6-dien-1-yl]oxyamino)methylidene]-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate can also be utilized in chemical research as a subject for studying the effects of its unique structural features on its potential applications and interactions with biological systems.
Please note that without specific information on the applications of (8E,14E,24E)-8-[({[(2E)-3,7-dimethylocta-2,6-dien-1-yl]oxy}amino)methylidene]-5,6,17,19-tetrahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,9,11-trioxo-1,2,8,9-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate, the uses provided are speculative based on its complex structure and potential for pharmaceutical or biological activities. Further research and experimentation would be required to confirm its actual uses and efficacy.
Check Digit Verification of cas no
The CAS Registry Mumber 41776-65-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,7,7 and 6 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 41776-65:
(7*4)+(6*1)+(5*7)+(4*7)+(3*6)+(2*6)+(1*5)=132
132 % 10 = 2
So 41776-65-2 is a valid CAS Registry Number.
41776-65-2Relevant academic research and scientific papers
Oximes of 3 formylrifamycin SV. Synthesis, antibacterial activity, and other biological properties
Cricchio,Lancini,Tamborini,Sensi
, p. 396 - 403 (2007/10/06)
The synthesis of the oximes of 3 formylrifamycin SV and the preparation of some of the O substituted hydroxylamine intermediates are described. The chemical and physical characteristics, the antibacterial activity on wild type and rifampicin resistant strains, and other biological properties of the new derivatives are reported. Structure activity relationships show that increasing the lipophilicity of the oxime substituent decreases the antibacterial activity, both in vitro and in experimental infection, whereas inhibition of a rifampicin resistant strain of S. aureus and of several transcribing enzymes is increased.
